Menu

Recipients of Experimental Herpes Vaccine File Lawsuit

The suit claims that Rational Vaccines, the company of recently deceased researcher William Halford, violated US and international laws when it carried out the procedure.

Mar 15, 2018
Catherine Offord

ISTOCK, BERNARDASVThree people who developed adverse side effects after receiving injections of an unapproved, experimental herpes vaccine have taken the matter to court, according to a lawsuit filed on Friday (March 9) in Illinois (via Kaiser Health News). Southern Illinois University researcher William Halford, who was responsible for the creation of the vaccine and the injections themselves, died last summer, but the recipients of his vaccine are claiming compensation from his company, Rational Vaccines, which they claim violated US and international laws that protect the rights of study participants.

“My clients are anxious to ensure such unethical experimentation on human subjects are not repeated,” Alan Milstein, a New Jersey lawyer who is representing the three participants, tells Kaiser Health News. The suit requests compensation for both the costs of medical care and for the “pain and suffering” and loss of dignity incurred by the participants.

Two of the procedures mentioned in the suit were carried out in 2016 as part of an unsanctioned trial in the Caribbean island nation St. Kitts and Nevis that included testing on 20 people. “The Ministry of Health states categorically that neither the Cabinet, the Ministry of Health, the office of Chief Medical Officer nor the St. Kitts and Nevis Medical Board has ever been approached on this project,” the country’s government noted afterwards (via Kaiser Health News). “By extension, none of these agencies has approved such a venture.”

The third procedure was performed in a hotel in Illinois, without the oversight of the US Food and Drug Administration (FDA). Kaiser Health News notes that Rational Vaccines, which Halford cofounded with filmmaker Agustín Fernández III in 2015, has not responded to request for comment on the most recent development, but has previously said it plans to continue testing the vaccine and working toward eventual FDA approval.

Meanwhile, Southern Illinois University is proceeding with a misconduct investigation relating to Halford’s research, and possible complicity among his colleagues.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.